Overview

Endometrial Rejuvenation Study

Status:
Terminated
Trial end date:
2021-05-04
Target enrollment:
Participant gender:
Summary
To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who are undergoing frozen-thawed embryo transfer. The investigators will assess associations between response to stem cell mobilization and pregnancy outcomes.
Phase:
N/A
Details
Lead Sponsor:
Reproductive Medicine Associates of New Jersey
Treatments:
Plerixafor
Plerixafor octahydrochloride